Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MEDAG mRNA | CTD | PMID:22079256 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of MEDAG mRNA | CTD | PMID:30165855 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:26705709 | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of MEDAG mRNA | CTD | PMID:37199045 | 3-chloropropane-1,2-diol | decreases expression | ISO | Medag (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in decreased expression of MEDAG mRNA | CTD | PMID:28522335 | 4,4'-sulfonyldiphenol | increases expression | ISO | Medag (Mus musculus) | 6480464 | bisphenol S results in increased expression of MEDAG mRNA | CTD | PMID:30951980 | 6-propyl-2-thiouracil | decreases expression | ISO | Medag (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of MEDAG mRNA | CTD | PMID:24780913 and PMID:25825206 | 8-Br-cAMP | increases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MEDAG mRNA | CTD | PMID:20147733 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of MEDAG mRNA | CTD | PMID:33167477 | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of MEDAG mRNA | CTD | PMID:24449571 | benzo[a]pyrene | increases expression | ISO | Medag (Rattus norvegicus) | 6480464 | Benzo(a)pyrene results in increased expression of MEDAG mRNA | CTD | PMID:21839799 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MEDAG mRNA | CTD | PMID:32234424 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of MEDAG 3' UTR and Benzo(a)pyrene results in increased methylation of MEDAG exon | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of MEDAG promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MEDAG mRNA | CTD | PMID:22316170 | bisphenol A | decreases expression | ISO | Medag (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of MEDAG mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Medag (Mus musculus) | 6480464 | bisphenol A results in increased expression of MEDAG mRNA | CTD | PMID:32156529 | bisphenol F | increases expression | ISO | Medag (Mus musculus) | 6480464 | bisphenol F results in increased expression of MEDAG mRNA | CTD | PMID:30951980 | cadmium atom | multiple interactions | ISO | Medag (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MEDAG mRNA | CTD | PMID:37325564 | cadmium dichloride | multiple interactions | ISO | Medag (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MEDAG mRNA | CTD | PMID:37325564 | cantharidin | decreases expression | ISO | Medag (Mus musculus) | 6480464 | Cantharidin results in decreased expression of MEDAG mRNA | CTD | PMID:36907384 | carbon nanotube | decreases expression | ISO | Medag (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chromium(6+) | decreases expression | EXP | | 6480464 | chromium hexavalent ion results in decreased expression of MEDAG mRNA | CTD | PMID:30690063 | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of MEDAG gene | CTD | PMID:22964155 | dioxygen | multiple interactions | ISO | Medag (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MEDAG mRNA | CTD | PMID:30529165 | diuron | decreases expression | ISO | Medag (Rattus norvegicus) | 6480464 | Diuron results in decreased expression of MEDAG mRNA | CTD | PMID:25152437 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of MEDAG mRNA | CTD | PMID:29803840 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of MEDAG mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEDAG mRNA | CTD | PMID:27188386 | fenvalerate | increases expression | ISO | Medag (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of MEDAG mRNA | CTD | PMID:30307764 | fluoranthene | multiple interactions | ISO | Medag (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MEDAG mRNA | CTD | PMID:28329830 | gentamycin | decreases expression | ISO | Medag (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of MEDAG mRNA | CTD | PMID:33387578 | manganese(II) chloride | increases expression | ISO | Medag (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of MEDAG mRNA | CTD | PMID:28801915 | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of MEDAG mRNA | CTD | PMID:24768652 and PMID:25583101 | nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of MEDAG mRNA | CTD | PMID:22714537 | oxybenzone | decreases expression | ISO | Medag (Rattus norvegicus) | 6480464 | oxybenzone results in decreased expression of MEDAG mRNA | CTD | PMID:30316929 | ozone | multiple interactions | ISO | Medag (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MEDAG mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MEDAG mRNA | CTD | PMID:34911549 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MEDAG mRNA | CTD | PMID:26690555 | paracetamol | decreases expression | ISO | Medag (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of MEDAG mRNA | CTD | PMID:33387578 | paraquat | increases expression | ISO | Medag (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of MEDAG mRNA | CTD | PMID:32680482 | perfluorohexanesulfonic acid | increases expression | ISO | Medag (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of MEDAG mRNA | CTD | PMID:37995155 | permethrin | increases expression | EXP | | 6480464 | Permethrin results in increased expression of MEDAG mRNA | CTD | PMID:37047231 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MEDAG mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of MEDAG mRNA | CTD | PMID:22079256 and PMID:22714537 | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of MEDAG mRNA | CTD | PMID:21795739 | rotenone | decreases expression | ISO | Medag (Rattus norvegicus) | 6480464 | Rotenone results in decreased expression of MEDAG mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of MEDAG mRNA | CTD | PMID:23806026 | thimerosal | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Thimerosal co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MEDAG mRNA | CTD | PMID:27188386 | titanium dioxide | decreases expression | ISO | Medag (Rattus norvegicus) | 6480464 | titanium dioxide results in decreased expression of MEDAG mRNA | CTD | PMID:30012374 | triclosan | increases expression | EXP | | 6480464 | Triclosan results in increased expression of MEDAG mRNA | CTD | PMID:30510588 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of MEDAG mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of MEDAG mRNA | CTD | PMID:24935251 | |